Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Evotec SE    EVT   DE0005664809

EVOTEC SE

(EVT)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/30/2019 | 10:45am EDT

DGAP Total Voting Rights Announcement: Evotec SE / Total Voting Rights Announcement
Evotec SE: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

30.04.2019 / 16:43
Total Voting Rights Announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of total number of voting rights

1. Details of issuer
Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany

2. Type of capital measure
  Type of capital measure Date of status / date of effect
X Conditional capital increase (Sec. 41 para. 2 WpHG) 30.04.2019
  Other capital measure (Sec. 41 para. 1 WpHG)

3. New total number of voting rights:
149796449



30.04.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: Evotec SE
Manfred Eigen Campus / Essener Bogen 7
22419 Hamburg
Germany
Internet: www.evotec.com

 
End of News DGAP News Service

805429  30.04.2019 

fncls.ssp?fn=show_t_gif&application_id=805429&application_name=news&site_id=zonebourse

© EQS 2019
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on EVOTEC SE
10/11CORRECTION OF A RELEASE FROM 30/09/2 : 52 CET/CEST - Evotec SE: Release accordin..
EQ
10/11EVOTEC : Just Evotec Biologics and Biocon Biologics sign licensing deal for a bi..
AQ
10/10EVOTEC : Just - evotec biologics & biocon biologics sign licensing deal for a bi..
EQ
10/09EVOTEC : and Celmatix enter into strategic collaboration
AQ
10/09EVOTEC : And celmatix enter into strategic collaboration
EQ
10/07EVOTEC : reaches milestone in integrated drug discovery and development partners..
AQ
10/04EVOTEC : Reaches milestone in integrated drug discovery and development partners..
EQ
09/30EVOTEC SE : Release according to Article 41 of the WpHG [the German Securities T..
EQ
09/30EVOTEC : And indivumed achieve milestone in joint strategic drug discovery colla..
EQ
09/26EVOTEC SE : Release according to Article 40, Section 1 of the WpHG [the German S..
EQ
More news
Financials (EUR)
Sales 2019 428 M
EBIT 2019 63,5 M
Net income 2019 41,9 M
Finance 2019 62,0 M
Yield 2019 -
P/E ratio 2019 69,5x
P/E ratio 2020 50,2x
EV / Sales2019 6,70x
EV / Sales2020 5,82x
Capitalization 2 925 M
Chart EVOTEC SE
Duration : Period :
Evotec SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EVOTEC SE
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 28,80  €
Last Close Price 19,47  €
Spread / Highest target 69,5%
Spread / Average Target 48,0%
Spread / Lowest Target 28,4%
EPS Revisions
Managers
NameTitle
Werner Lanthaler Chief Executive Officer
Wolfgang Plischke Chairman-Supervisory Board
Craig L. Johnstone Chief Operating Officer & Member-Management Board
Enno Spillner Chief Financial Officer
Cord E. Dohrmann Chief Scientific Officer
Sector and Competitors
1st jan.Capitalization (M$)
EVOTEC SE12.09%3 259
IQVIA HOLDINGS INC.23.52%28 109
LONZA GROUP31.76%25 271
CELLTRION, INC.--.--%19 657
INCYTE CORPORATION22.28%16 724
SEATTLE GENETICS, INC.54.25%14 852